View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Comment
April 28, 2020

More than half of age-related macular degeneration cases go undiagnosed in major pharmaceutical markets

Age-related macular degeneration (AMD) is a progressive eye disease that affects the retina, the area of the eye responsible for central vision and sharpness. AMD is the most common cause of irreversible vision loss among the elderly, specifically those ages 50 years and older.

By GlobalData Healthcare

Age-related macular degeneration (AMD) is a progressive eye disease that affects the retina, the area of the eye responsible for central vision and sharpness. AMD is the most common cause of irreversible vision loss among the elderly, specifically those ages 50 years and older. In the nine major pharmaceutical markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, Australia, and China), GlobalData epidemiologists found that less than half of AMD cases were diagnosed in 2019, with Japan and China experiencing the most undiagnosed cases due to the large number of AMD cases in these markets (as shown in Figure 1).

Primary eye care providers are often the first line of defense in detecting eye disease. However, a 2017 study published in JAMA Ophthalmology by Neely and colleagues revealed that a large number of AMD cases go undetected and undiagnosed in the primary eye care setting. The study examined elderly patients without diagnosed eye conditions, and found that 320 of 1,288 eyes had AMD. The results of this study are concerning, indicating that under-diagnosis of AMD can easily occur in the primary care setting and is likely driving the gap between diagnosed and undiagnosed cases.

Accurate and timely identification of AMD cases in the primary eye care setting is critical for improving patient outcomes. Future efforts should prioritise addressing gaps in physician awareness and providing better training opportunities on how to properly assess and diagnose AMD.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology